The Role and Validity of Diagnostic Biomarkers in Late-Onset Neonatal Sepsis.
biomarkers
diagnosis
late-onset
neonatal
sepsis
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
accepted:
10
08
2021
entrez:
15
9
2021
pubmed:
16
9
2021
medline:
16
9
2021
Statut:
epublish
Résumé
Sepsis remains a leading cause of mortality in the neonatal population, and currently, there is still no consensus on an accurate biomarker that can aid prompt diagnosis. This review focuses on studies investigating biomarkers for late-onset neonatal sepsis specifically. We discuss the current evidence for traditionally used biomarkers and present recent developments on more novel markers. Suitable articles were selected from PubMed, Embase, Medline, Cochrane Handbook of Systematic Reviews, and ScienceDirect. Inclusion criteria were studies published from 2010 to 2020. Exclusion criteria were animal model-based studies. Keywords in search strategy were late-onset neonatal sepsis + biomarkers + diagnosis. Evidence is growing increasingly weak for commonly studied biomarkers such as C-reactive protein (CRP) and procalcitonin (PCT). Levels of markers such as Serum Amyloid A and Neutrophil CD64 increase more rapidly post-onset of infection compared to CRP. Moreover, this review found that the more novel biomarkers discussed such as presepsin and endocan may show superior and more promising potential as diagnostic markers. However, larger studies over multicenters are deemed essential to ascertain the ideal biomarker.
Identifiants
pubmed: 34522543
doi: 10.7759/cureus.17065
pmc: PMC8428627
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e17065Informations de copyright
Copyright © 2021, Mwesigye et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Microb Pathog. 2017 Jun;107:234-242
pubmed: 28377234
Pediatr Crit Care Med. 2013 Feb;14(2):178-82
pubmed: 23314180
J Matern Fetal Neonatal Med. 2012 Oct;25(Suppl 5):51-3
pubmed: 23025769
Arch Dis Child Fetal Neonatal Ed. 2015 May;100(3):F257-63
pubmed: 25425653
Intensive Care Med. 2007 Jan;33(1):13-24
pubmed: 17093985
BMC Pediatr. 2018 Jan 30;18(1):16
pubmed: 29382319
J Infect Chemother. 2012 Dec;18(6):891-7
pubmed: 22692596
Indian J Pharmacol. 2014 Nov-Dec;46(6):579-83
pubmed: 25538326
J Matern Fetal Neonatal Med. 2011 Oct;24 Suppl 2:12-4
pubmed: 21740312
Cochrane Database Syst Rev. 2019 Jan 14;1:CD012126
pubmed: 30640979
Crit Care Med. 2006 Oct;34(10):2596-602
pubmed: 16915118
PLoS One. 2015 Apr 20;10(4):e0124634
pubmed: 25894336
Br J Surg. 1996 Sep;83(9):1186-96
pubmed: 8983604
Rev Chilena Infectol. 2012 Oct;29(5):511-6
pubmed: 23282492
J Clin Invest. 2010 Aug;120(8):2989-3000
pubmed: 20592468
BMC Infect Dis. 2019 Aug 6;19(1):695
pubmed: 31387523
Genome Med. 2010 Sep 06;2(9):58
pubmed: 20828428
Pediatrics. 2015 Jan;135(1):68-75
pubmed: 25511124
Early Hum Dev. 2017 Feb;105:25-33
pubmed: 28131458
Int J Infect Dis. 2011 Dec;15(12):e854-8
pubmed: 22019570
J Matern Fetal Neonatal Med. 2016;29(11):1834-9
pubmed: 26135765